Stocktoria
Health In Tech, Inc. HIT
Nasdaq · stock · Insurance Agents, Brokers & Service · website · IPO 2024-12-23
Health In Tech, Inc. financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $37.6M | $19.6M | $19.2M |
| Gross profit | $20.9M | $15.4M | $16.8M |
| R&D expense | $1.6M | $2.8M | $2.0M |
| Income tax | $395,330 | $218,523 | $945,236 |
| Net income | $1.3M | $670,477 | — |
| EPS (diluted) | $0.02 | $0.01 | — |
| Operating cash flow | $3.1M | $2.2M | $1.5M |
| Cash & equivalents | $7.7M | $7.8M | $2.4M |
| Total assets | $23.1M | $15.8M | $11.5M |
| Total liabilities | $6.0M | $2.6M | $5.4M |
| Shareholders' equity | $17.1M | $13.2M | $6.1M |
Growth · year-over-year · Revenue CAGR 39.7%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +91.7% | +1.8% | — |
| Net income growth | +90.7% | — | — |
| EPS growth | +100.0% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.